Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Other Accumulated Expenses (2016 - 2025)

Dexcom (DXCM) has disclosed Other Accumulated Expenses for 15 consecutive years, with $45.8 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 23.45% to $45.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.8 million through Dec 2025, up 23.45% year-over-year, with the annual reading at $45.8 million for FY2025, 23.45% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $45.8 million at Dexcom, up from $42.0 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $62.9 million in Q1 2022, with the low at $36.7 million in Q3 2024.
  • Average Other Accumulated Expenses over 5 years is $45.7 million, with a median of $46.1 million recorded in 2024.
  • The sharpest move saw Other Accumulated Expenses soared 69.28% in 2021, then dropped 27.29% in 2022.
  • Over 5 years, Other Accumulated Expenses stood at $54.6 million in 2021, then fell by 27.29% to $39.7 million in 2022, then rose by 2.02% to $40.5 million in 2023, then fell by 8.4% to $37.1 million in 2024, then grew by 23.45% to $45.8 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $45.8 million, $42.0 million, and $42.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.